Overview of Primary Malignant Tumors Affecting the Hip

Abstract

Malignancy within the hip joint can present with nonspecific symptoms such as a limp, joint stiffness, and pain. While malignant disease within the hip joint is not as common as in other areas of the body, its recognition is important, as a delay in proper diagnosis may be detrimental to patient outcomes. The authors present an overview of several malignant disease processes involving the hip joint as well as the senior author's preferred technique for endoprosthetic reconstruction in treating these conditions.

Keywords

orthopaedic oncology - tumor - malignant - sarcoma - endoprosthesis

• References

• 1 Bielack S, Carrle D, Jost L. ; ESMO Guidelines Working Group. Osteosarcoma: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 2008; 19 (Suppl. 02) ii94-ii96
• 2 Chandrasekar CR, Grimer RJ, Carter SR. , et al. Pathological fracture of the proximal femur in osteosarcoma: need for early radical surgery?. ISRN Oncol 2012; 2012: 512389
• 3 Stark A, Kreicbergs A, Nilsonne U, Silfverswärd C. The age of osteosarcoma patients is increasing. An epidemiological study of osteosarcoma in Sweden 1971 to 1984. J Bone Joint Surg Br 1990; 72 (01) 89-93
• 4 Dahan M, Anract P, Babinet A, Larousserie F, Biau D. Proximal femoral osteosarcoma: diagnostic challenges translate into delayed and inappropriate management. Orthop Traumatol Surg Res 2017; 103 (07) 1011-1015
• 5 Entz-Werle N, Schneider A, Kalifa C. , et al. Genetic alterations in primary osteosarcoma from 54 children and adolescents by targeted allelotyping. Br J Cancer 2003; 88 (12) 1925-1931
• 6 Bielack SS, Kempf-Bielack B, Delling G. , et al. Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol 2002; 20 (03) 776-790
• 7 Chou AJ, Geller DS, Gorlick R. Therapy for osteosarcoma: where do we go from here?. Paediatr Drugs 2008; 10 (05) 315-327
• 8 Bielack S, Jürgens H, Jundt G. , et al. Osteosarcoma: the COSS experience. Cancer Treat Res 2009; 152: 289-308
• 9 Durfee RA, Mohammed M, Luu HH. Review of osteosarcoma and current management. Rheumatol Ther 2016; 3 (02) 221-243
• 10 Grimer RJ. Surgical options for children with osteosarcoma. Lancet Oncol 2005; 6 (02) 85-92
• 11 Bacci G, Ferrari S, Lari S. , et al. Osteosarcoma of the limb. Amputation or limb salvage in patients treated by neoadjuvant chemotherapy. J Bone Joint Surg Br 2002; 84 (01) 88-92
• 12 Biermann JS, Chow W, Reed DR. , et al. NCCN guidelines insights: bone cancer, version 2.2017. J Natl Compr Canc Netw 2017; 15 (02) 155-167
• 13 Bhadra AK, Pollock R, Tirabosco RP. , et al. Primary tumours of the synovium. A report of four cases of malignant tumour. J Bone Joint Surg Br 2007; 89 (11) 1504-1508
• 14 Rybak LD, Khaldi L, Wittig J, Steiner GC. Primary synovial chondrosarcoma of the hip joint in a 45-year-old male: case report and literature review. Skeletal Radiol 2011; 40 (10) 1375-1381
• 15 Grier HE, Krailo MD, Tarbell NJ. , et al. Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone. N Engl J Med 2003; 348 (08) 694-701
• 16 Steiner GCJG, Martignetti JA. Malignant fibrous histiocytoma of bone. In: Fletcher CDM UK, Mertens F. , eds. World Health Organization Classification of Tumours Pathology and Genetics of Tumours of Soft Tissue and Bone: Lyon: IARC Press; 2002: 294-296
• 17 Belal A, Kandil A, Allam A. , et al. Malignant fibrous histiocytoma: a retrospective study of 109 cases. Am J Clin Oncol 2002; 25 (01) 16-22
• 18 Nishida J, Sim FH, Wenger DE, Unni KK. Malignant fibrous histiocytoma of bone. A clinicopathologic study of 81 patients. Cancer 1997; 79 (03) 482-493
• 19 Koplas MC, Lefkowitz RA, Bauer TW. , et al. Imaging findings, prevalence and outcome of de novo and secondary malignant fibrous histiocytoma of bone. Skeletal Radiol 2010; 39 (08) 791-798
• 20 Natarajan MV, Mohanlal P, Bose JC. Limb salvage surgery complimented by customised mega prostheses for malignant fibrous histiocytomas of bone. J Orthop Surg (Hong Kong) 2007; 15 (03) 352-356
• 21 Patel SR. Radiation-induced sarcoma. Curr Treat Options Oncol 2000; 1 (03) 258-261
• 22 Huvos AG, Woodard HQ, Cahan WG. , et al. Postradiation osteogenic sarcoma of bone and soft tissues. A clinicopathologic study of 66 patients. Cancer 1985; 55 (06) 1244-1255
• 23 Mavrogenis AF, Pala E, Guerra G, Ruggieri P. Post-radiation sarcomas. Clinical outcome of 52 patients. J Surg Oncol 2012; 105 (06) 570-576
• 24 Keel SB, Jaffe KA, Petur Nielsen G, Rosenberg AE. Orthopaedic implant-related sarcoma: a study of twelve cases. Mod Pathol 2001; 14 (10) 969-977
• 25 Visuri T, Pulkkinen P, Paavolainen P. Malignant tumors at the site of total hip prosthesis. Analytic review of 46 cases. J Arthroplasty 2006; 21 (03) 311-323
• 26 Dorfman HD, Czerniak B. Bone cancers. Cancer 1995; 75 (1, Suppl): 203-210
• 27 Papagelopoulos PJ, Galanis E, Frassica FJ, Sim FH, Larson DR, Wold LE. Primary fibrosarcoma of bone. Outcome after primary surgical treatment. Clin Orthop Relat Res 2000; (373) 88-103
• 28 Larsson SE, Lorentzon R, Boquist L. Fibrosarcoma of bone. A demographic, clinical and histopathological study of all cases recorded in the Swedish cancer registry from 1958 to 1968. J Bone Joint Surg Br 1976; 58-B [phone]
• 29 Kumar R, Madewell JE, Lindell MM, Swischuk LE. Fibrous lesions of bones. Radiographics 1990; 10 (02) 237-256
• 30 Fox EJ, Hau MA, Gebhardt MC, Hornicek FJ, Tomford WW, Mankin HJ. Long-term followup of proximal femoral allografts. Clin Orthop Relat Res 2002; (397) 106-113
• 31 Donati D, Giacomini S, Gozzi E, Mercuri M. Proximal femur reconstruction by an allograft prosthesis composite. Clin Orthop Relat Res 2002; (394) 192-200
• 32 Bickels J, Meller I, Henshaw RM, Malawer MM. Reconstruction of hip stability after proximal and total femur resections. Clin Orthop Relat Res 2000; (375) 218-230
• 33 Finstein JL, King JJ, Fox EJ, Ogilvie CM, Lackman RD. Bipolar proximal femoral replacement prostheses for musculoskeletal neoplasms. Clin Orthop Relat Res 2007; 459 (459) 66-75
• 34 Kabukcuoglu Y, Grimer RJ, Tillman RM, Carter SR. Endoprosthetic replacement for primary malignant tumors of the proximal femur. Clin Orthop Relat Res 1999; (358) 8-14
• 35 Unwin PS, Cannon SR, Grimer RJ, Kemp HB, Sneath RS, Walker PS. Aseptic loosening in cemented custom-made prosthetic replacements for bone tumours of the lower limb. J Bone Joint Surg Br 1996; 78 (01) 5-13
• 36 Jeys LM, Grimer RJ, Carter SR, Tillman RM. Periprosthetic infection in patients treated for an orthopaedic oncological condition. J Bone Joint Surg Am 2005; 87 (04) 842-849
• 37 Gosheger G, Gebert C, Ahrens H, Streitbuerger A, Winkelmann W, Hardes J. Endoprosthetic reconstruction in 250 patients with sarcoma. Clin Orthop Relat Res 2006; 450 (450) 164-171
• 38 Menendez LR, Ahlmann ER, Kermani C, Gotha H. Endoprosthetic reconstruction for neoplasms of the proximal femur. Clin Orthop Relat Res 2006; 450 (450) 46-51
• 39 Chandrasekar CR, Grimer RJ, Carter SR, Tillman RM, Abudu A, Buckley L. Modular endoprosthetic replacement for tumours of the proximal femur. J Bone Joint Surg Br 2009; 91 (01) 108-112
• 40 van Kampen M, Grimer RJ, Carter SR, Tillman RM, Abudu A. Replacement of the hip in children with a tumor in the proximal part of the femur. J Bone Joint Surg Am 2008; 90 (04) 785-795